Labcorp (LH)
(Delayed Data from NYSE)
$226.91 USD
+3.00 (1.34%)
Updated Sep 9, 2024 04:00 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
LH 226.91 +3.00(1.34%)
Will LH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LH
Should You Hold Labcorp (LH) Stock in Your Portfolio Now?
Labcorp (LH) Gains From New Collaborations Amid FX Issues
LH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Labcorp (LH) Q2 Earnings Surpass Estimates (revised)
Labcorp (LH) Q2 Earnings Surpass Estimates, Margins Increase
Compared to Estimates, Labcorp (LH) Q2 Earnings: A Look at Key Metrics
Other News for LH
Catalyst Watch: Apple's iPhone event, Oracle earnings, Google antitrust trial, and the August CPI print
Labcorp to Speak at the Baird 2024 Global Healthcare Conference
Labcorp Executives to Present at Global Healthcare Conference
Ex-Dividend Reminder: Labcorp Holdings, Cathay General Bancorp and Kinsale Capital Group
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain